PBPH ETF — Portfolio Building Block World Pharma and Biotech Index ETF

Portfolio Building Block World Pharma and Biotech Index ETF (PBPH)

Updated October 16, 2026.

PBPH is a low-cost ETF. its trailing-12-month yield is 0.08%, its expense ratio is 0.13%. Dividend Vision Distribution Safety Score™ is 50/100 (Unproven). Total return is 16.4% over the past 0.9 years, 2.1 points ahead of SPY at 14.3%.

This ETF tracks a rules-based index of pharmaceutical and biotechnology companies with publicly traded shares on major developed-market exchanges, using a passive management approach and holding at least 80% of its assets in index component securities. The fund has a very modest distribution rate with annual distributions, though its latest payout was special and may not recur regularly; it carries a low expense ratio of 0.13%. The fund appeals to investors seeking broad exposure to global pharma and biotech equities through a low-cost, passively managed structure.

PBPH performance versus SPY

Price and return data through 2026-10-16.

Total return is 16.4% over the past 0.9 years, 2.1 points ahead of SPY at 14.3%. Its deepest 1-year drawdown was 11.1%.

PBPH key facts

Distribution Safety Score™

50 · Unproven

Issuer

Portfolio Building Block

Asset type

ETF

Asset class

Equity

Inception date

11/25/2025

Expense ratio

0.13%

Distribution frequency

Annual

Trailing yield

0.08%

Last close

$29.15 (as of 2026-10-16)

AUM

$1,024,008,090

Average volume

99100.0

Dividend

$0.023

Ex-dividend date

12/24/2025

Payment date

12/26/2025

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield (0.08%) is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: Portfolio Building Block; prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

PBPH risks and drawbacks

Payments are annual, so cash flow is lumpy versus a monthly fund. The deepest 1-year drawdown on record here is 11.1%.

Who may consider PBPH — and who may not

PBPH may suit someone looking for low-cost broad dividend exposure. It is a weaker fit for investors who need monthly cash flow (PBPH pays annual). This is educational context, not a recommendation to buy or sell.

More on PBPH

• All tickers starting with P

Tagged: Healthcare, Pharmaceutical, Index.

Frequently asked questions

More securities from Portfolio Building Block.